,
Dube, Umber
,
Ibanez, Laura
Budde, John P.
Benitez, Bruno A.
Davis, Albert A.
Harari, Oscar
Iles, Mark M.
Law, Matthew H.
Brown, Kevin M.
Cruchaga, Carlos https://orcid.org/0000-0002-0276-2899
Funding for this research was provided by:
National Institutes of Health (R01AG044546)
National Institutes of Health (P01AG003991)
National Institutes of Health (RF1AG053303)
National Institutes of Health (R01AG058501)
National Institutes of Health (U01AG058922)
National Institutes of Health (K08NS101118)
National Institutes of Health (R01HL119813)
Alzheimer's Association (NIRG-11-200110)
Alzheimer's Association (BAND-14-338165)
Alzheimer's Association (AARG-16-441560)
Alzheimer's Association (BFG-15-362540)
Hope Center for Neurological Disorders
Article History
Received: 5 September 2019
Revised: 29 November 2019
Accepted: 4 December 2019
First Online: 16 December 2019
Change Date: 14 March 2020
Change Type: Correction
Change Details: The original version of this article unfortunately contained a mistake. Supplementary Tables��3 and 4 are not available with the rest of the supplementary material available online.
Compliance with ethical standards
:
: CC receives research support from: Biogen, EISAI, Alector and Parabon. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. CC is a member of the advisory board of ADx Healthcare, Halia Therapeutics and Vivid Genomics.